Key result
Maternal hypertensive disorders linked to a ~2.3-week earlier delivery in fetal CHD pregnancies.
Why the study?
Although delivery after 39 weeks gestation is recommended for fetuses with congenital heart disease, hypertensive disorders of pregnancy, maternal diabetes, and fetal growth restriction often necessitate earlier delivery. This study evaluated indications for delivery before 39 weeks and examined associated maternal covariates, cardiac diagnoses, and placental pathology.
What are the indications, maternal/placental risk factors, and neonatal mortality outcomes associated with delivery at <39 weeks' gestation in fetuses with congenital heart disease?
Cohort (n=214)
No
What are the indications, maternal/placental risk factors, and neonatal mortality outcomes associated with delivery at <39 weeks' gestation in fetuses with congenital heart disease?
Nearly half of infants with isolated fetal congenital heart disease are delivered before the recommended 39 weeks largely due to maternal and placental complications like hypertensive disorders, which carry a higher risk of neonatal mortality.
Answers are grounded in this paper and cite their sources.
HDP in fetal CHD may drive earlier delivery and higher mortality; leaves open whether maternal optimization extends gestation.
Objective: Delivery >39 weeks’ gestation is recommended for fetuses with congenital heart disease (FCHD). However, hypertensive disorders of pregnancy (HDP), maternal diabetes and fetal growth restriction (FGR) are more common in these pregnancies and often necessitate early delivery. We evaluated indications for delivery at <39 weeks and examined maternal covariates, cardiac diagnoses and placental pathology. Study Design: This retrospective observational study included maternal-fetal dyads with prenatally diagnosed, structurally isolated, genetically unremarkable FCHD delivered at a single center. Gestational age and delivery indication were obtained from medical record. Placental pathology was assessed using Amsterdam criteria. Regression models evaluated associations with gestational age and neonatal mortality. Results: 46.3% (99/214) delivered <39 weeks; 65.6% (65/99) were due to maternal or fetal compromise, and 34.3% (33/99) to obstetric indications. HDP (20.1%) was strongly associated with <39-week delivery (32.3% vs 9.6%, p<0.001) and the greatest reduction in gestational age (−2.31 weeks, p<0.001). Multivariable analysis identified preeclampsia, type 2 diabetes, lower birthweight Z-score, and race as independent predictors of earlier delivery (p<0.05). Neonatal mortality was higher with maternal/fetal indications (15.7%) versus obstetric (5.4%) or elective FCHD delivery (5.6%) (p=0.02). Conclusion: Nearly half of FCHD infants delivered before 39 weeks, largely due to maternal and placental disease, underscoring the importance of placental health in this population.
No takes yet. Share an insight, caveat, or question.
Packer et al. (2026) conducted a cohort in Fetal congenital heart disease (n=214). Delivery at <39 weeks' gestation (associated with maternal/fetal compromise or hypertensive disorders of pregnancy) vs. Delivery at ≥39 weeks' gestation (or obstetric/elective delivery indications) was evaluated on Delivery at <39 weeks' gestation and associated neonatal mortality (MD -2.31, p=<0.001). Hypertensive disorders of pregnancy were strongly associated with <39-week delivery in fetal CHD and a -2.31 week gestational age reduction.
Synapse has enriched 10 related papers. Consider them for comparative context: